LifeSprout, Inc. is a privately held company developing revolutionary products for aesthetic and regenerative medicine. The company's Regenerative Matrix platform leverages advances in materials science to create products that look and feel like the body's own tissues. LifeSprout is turning this technology into a suite of products for the millions of patients with tissue losses from aging, cancer, metabolic disease, and orphan indications. The company's lead product Lumina™ is a breakthrough family of aesthetic fillers enabling immediate, natural restoration with biostimulatory effects. LifeSprout's next generation cell therapy products use the power of the platform to promote true tissue regeneration.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/28/20 | $28,500,000 | Series A |
Abell Foundation Emerald Development Managers Nexus Management Redmile Group  | undisclosed |
